glp-1 dementia Can popular diabetes and weight-loss drugs slow vascular dementia? GLP-1 Drugs Target the Roots

Delayed gastric emptying, where the stomach empties slower than normal, can be caused by a variety of factors leading to symptoms such as bloating and fullness

These leading pharmaceutical firms focus on developing innovative cardiovascular therapies, such as next-generation anticoagulants, lipid-lowering agents, and combination antihypertensive drugs, to address the growing burden of heart diseases globally

Efficacy and safety of the combination or monotherapy with GLP-1 receptor agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: an update systematic review and meta-analysis

Che-Yuan Wu is supported by the Canadian Institutes of Health Research (Doctoral Research Award: Canadian Graduate Scholarships